Auryxia Drug Class, GPI: 52800030100320 Akebia Therapeutics, Inc. Choose the indication you are prescribing for and lea...

Auryxia Drug Class, GPI: 52800030100320 Akebia Therapeutics, Inc. Choose the indication you are prescribing for and learn what AURYXIA can do for your patients. , hemochromatosis WARNINGS AND Adverse reactions to a drug are most readily ascertained by comparison with placebo, but there is little placebo-controlled experience with Auryxia, so this section describes adverse events with Auryxia, Detailed dosage guidelines and administration information for Auryxia (ferric citrate). Diarrhea was the Use in Children: Not indicated. It works to control high blood levels of phosphorus by binding phosphorus that you get from Officials with the FDA have expanded the approval of ferric citrate (Auryxia, Keryx Biopharmaceuticals) tablets to include the treatment of adults with iron deficiency anemia and Ferric citrate Prices, Coupons, Copay Cards & Patient Assistance Prices Coupons Patient assistance Ferric citrate is a member of the phosphate binders drug class and is commonly used for The code 59922-631-01 identifies a specific commercial package of 200 tablet, film coated in 1 bottle of Auryxia, a human prescription drug labeled by Akebia Purpose This guide provides an overview of billing and coding related to AURYXIA. 1 Pregnancy - Risk Summary - There are no available data on Auryxia use in pregnant women to inform a drug-associated risk of major birth defects and miscarriage. (1) Auryxia is an In September 2014, ferric citrate (Auryxia, Keryx Biopharmaceuticals), a novel phosphate-binding agent, received Food and Drug Administration approval for the treatment of hyperphosphatemia in CKD 4. Was ist Auryxia und wie wird es angewendet? Auryxia (Eisen (III) -citrat) ist ein Phosphatbindemittel zur Kontrolle des Serumphosphorspiegels bei Patienten mit chronischer Nierenerkrankung unter Dialyse. The AURYXIA is a unique formulation of ferric citrate coordination complexes indicated for the control of serum phosphorus levels in adults with CKD receiving dialysis. Andere Medikamente können Auryxie beeinflussen, darunter Overview: Auryxia is used to treat high phosphate levels and iron deficiency anemia in certain people. Common side effects include change in Wirkstoffklasse: Phosphatbinder. Medscape - Hyperphosphatemia and anemia dosing for ferric citrate (Auryxia), frequency-based adverse effects, comprehensive interactions, contraindications, Auryxia contains the active ingredient ferric citrate in the form of ferric iron tablets. An antibiotic called doxycycline: take Auryxia at least 1 hour before you take Auryxia. Of the total drug interactions, 5 are major, 46 are FDA Approves New Indication for Auryxia Officials with the FDA have expanded the approval of ferric citrate (Auryxia, Keryx Biopharmaceuticals) tablets to include the treatment of The drug Auryxia (ferric citrate) has a special formulation that enables it to both increase iron levels in patients with CKD who are not receiving dialysis and decrease phosphate levels in Auryxia kann auch für Zwecke verwendet werden, die nicht in diesem Medikamentenleitfaden aufgeführt sind. Includes: indications, dosage, adverse reactions and pharmacology. This review focuses on Auryxia, its mechanism of action, and the clinical attributes that differentiate it from other, non-pharmaceutical-grade, Includes Ferric Citrate indications, dosage/administration, pharmacology, mechanism/onset/duration of action, half-life, dosage forms, interactions, warnings, adverse 5. AURYXIA Film-coated tablet Ref. Auryxia is also known as Ferric Citrate Tablets. , Keryx Biopharmaceuticals, Inc. Auryxia (Tetraferric Tricitrate Decahydrate). An antibiotic called ciprofloxacin: take it at least 2 hours before or 2 hours after you take Auryxia. Auryxia (Ferric Citrate Tablets) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison and health resources. It is labeled and distributed by Akebia Therapeutics, Inc. Discover more about Auryxia, including its uses, side effects, dosage, images, and alternative medications. Get all the details about Auryxia from MedicinesFAQ. It is not intended to serve as a comprehensive training for medical billing and coding. Auryxia ® (ferric citrate; Keryx Biopharmaceuticals, Inc. Akebia Therapeutics Inc. There are no empirical data on avoiding drug FDA approval history for Auryxia (ferric citrate) used to treat Hyperphosphatemia of Renal Failure, Anemia Due to Chronic Kidney Disease. Drug Interactions Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. Patients FDA Structured Product Label (SPL) for Auryxia (NDC 59922-631). The primary component is 8. The primary component is NDC 59922-631 Auryxia Ferric Citrate Auryxia is a Oral Tablet, Film Coated in the Human Prescription Drug category. Full prescribing info, side effects, interactions & warnings. Auryxia drug information: uses, indications, side effects, dosage. : Auryxia is a phosphate binder indicated for the control of serum phosphorus levels in adult patients with chronic kidney disease on dialysis. In addition, for One Care, certain anti-obesity drugs are covered under Official AURYXIA® (ferric citrate) website for US healthcare professionals. com, including related drug classes, side effects, dosage, and answers to frequently asked questions. The medication is available as film-coated, Auryxia package insert / prescribing information for healthcare professionals. , Boston, MA, USA) is an iron-based compound with distinctive chemical characteristics and a mechanism of action that render it dually effective as a Auryxia ® (ferric citrate; Keryx Biopharmaceuticals, Inc. AURYXIA Market Exclusivity Period (MEP), patent landscape, 505(b)2 developments, alternate formulations, international patents, generic Please refer to your supplemental new drug application (sNDA) dated and received July 21, 2023, submitted under section 505(b) of the Federal Food, Drug, and Cosmetic Act (FDCA) for Auryxia Generic Name: ferric citrate tablets Brand Name: Auryxia Drug Class: Iron Products Auryxia (Ferric Citrate Tablets) side effects drug center Related Drugs Fosrenol Glofil-125 Hectorol Hectorol Auryxia Interactions There are 53 drugs known to interact with Auryxia (ferric citrate), along with 1 disease interaction, and 1 alcohol/food interaction. [10060] Active ingredients: Ferric citrate Source: FDA, National Drug Code (US) Revision Year: 2019 Auryxia® (ferric citrate; Keryx Biopharmaceuticals, Inc. . Explore Auryxia dosage, 100+ drug interactions, and generic alternatives. Was ist Aurixie? Auryxia enthält Eisen, das sich an die Phosphate bindet, die Sie über die Nahrung aufnehmen, wodurch Ihr Körper weniger Phosphate Drug Description What is Auryxia and how is it used? Auryxia (ferric citrate) is a phosphate binder used for the control of serum phosphorus levels in patients with chronic kidney disease on dialysis. does not In vivo Six drug interaction studies (N=26-60/study) were conducted to establish the effects of Auryxia (administered as 3 x 2 g/day with meals) on the disposition of concomitantly orally administered Ferric citrate is in a class of medications called phosphate binders and iron replacement products. Compare Auryxia head-to-head with other drugs for uses, ratings, cost, side effects and interactions. , Brand Names Auryxia Generic Name Tetraferric tricitrate decahydrate Commonly known or available as Ferric citrate DrugBank Accession Number DB14520 Background Tetraferric tricitrate NDC 59922-631 Auryxia Ferric Citrate Auryxia is a Oral Tablet, Film Coated in the Human Prescription Drug category. Auryxia Nebenwirkungen Suchen Sie sofort medizinische Hilfe, wenn Sie Anzeichen einer Ferric citrate is in a class of medications called phosphate binders and iron replacement products. Review professional prescribing information, including 1. Supplied by Keryx Biopharmaceuticals, Inc. [10060] Active ingredients: Ferric citrate Source: FDA, National Drug Code (US) Revision Year: 2019 This review focuses on Auryxia, its mechanism of action, and the clinical attributes that differentiate it from other, non-pharmaceutical-grade, SPECIFIC POPULATIONS Pregnancy and Lactation: There are no available data on AURYXIA use in pregnant women to inform a drug-associated risk of major Find drug information for Ferric Citrate DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, Class Antianaemics; Ferric compounds; Hyperphosphataemia therapies; Small molecules; Tricarboxylic acids; Urologics Mechanism of Action Phosphate binding modulators Orphan Drug Status Orphan Tufts Health Together utilizes MassHealth’s Unified Formulary for pharmacy medications and select medical benefit drugs. Increases in serum ferritin and transferrin saturation Ferric citrate Generic name: ferric citrate [ FER-ik-SIT-rate ] Brand name: Auryxia Dosage form: oral tablet (210 mg) Drug class: Phosphate binders Ferric citrate Generic name: ferric citrate [ FER-ik-SIT-rate ] Brand name: Auryxia Dosage form: oral tablet (210 mg) Drug class: Phosphate binders Mechanism of action of AURYXIA Watch this video and see how AURYXIA, an oral iron tablet, works in adult patients. 24. Read Important Safety Information and Full Prescribing information on this page. Read about treatment with AURYXIA® (ferric citrate) tablets and examine pivotal trial data and trial design. Compare Auryxia's side effects + efficacy. com. , Patheon Inc. Taking this medicine with any of the following medications may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. Ferric citrate (Auryxia) Pregnancy Risk Category: N (Not assigned) The drug has not been studied in animal or human pregnancy This review focuses on Auryxia, its mechanism of action, and the clinical attributes that differentiate it from other, non-pharmaceutical-grade, commercially available Ferric Citrate (Monograph) Brand name: Auryxia Drug class: Phosphate-reducing Agents Chemical name: 2-Hydroxy-1,2,3-propanetricarboxylic acid iron (III) hydrate Molecular formula: C 6 H 5 FeO 7 AURYXIA Film-coated tablet Ref. 1 hyperphosphatemia in chronic During the 16-week, placebo-control trial, 12 patients (10%) on Auryxia discontinued study drug because of an adverse reaction, as compared to 10 patients (9%) in the placebo control arm. Know about technical details of AURYXIA like: chemical name, chemistry structure, formulation, uses, toxicity, action, side effects and more at Pharmacompass. Compare prices for generic auryxia substitutes: Accrufer, Active FE, Beef,Iron & Wine Akebia Therapeutics, Inc. For oral medications where a reduction in the bioavailability of that medication would have a Find Auryxia side effects, uses, warnings, interactions and indications. Animal reproduction studies Auryxia decreased the relative bioavailability of concomitantly administered ciprofloxacin by approximately 45%. Includes dose adjustments, warnings and precautions. Iron absorption from Auryxia may lead to excessive elevations in iron stores. g. Read Important Safety Information and Prescribing Information on Learn about Auryxia uses, dosage, side effects, food interactions, and more. Last updated on Apr 21, 2025. Drug Interactions: Auryxia has the potential to interact with other medications. 1,2,5 AURYXIA is an iron-based, Authorization and marketing This drug has been assigned below unique identifiers within the countries it is being marketed: Auryxia by is a Prescription medication manufactured, distributed, or labeled by Akebia Therapeutics, Inc. It belongs to the phosphate binder and iron replacement product class. Which are the Pharmacologic Classes for Auryxia? A pharmacologic class is a group of drugs that share the same scientifically documented properties. However, there was no interaction when Auryxia and ciprofloxacin were taken 2 Auryxia Tablet Drug overview for AURYXIA (ferric citrate): Generic name: FERRIC CITRATE (FER-us SI-trate) Drug class: Iron Therapeutic class: Genitourinary Therapy Ferric citrate is a phosphate Ferric Citrate is a prescription medication used to control serum phosphorus levels in patients with chronic kidney disease on dialysis or for treating iron deficiency This review focuses on Auryxia, its mechanism of action, and the clinical attributes that differentiate it from other, non-pharmaceutical-grade, commercially available forms of ferric citrate and from other The drug Auryxia (ferric citrate) has a special formulation that enables it to both increase iron levels in patients with CKD who are not receiving dialysis and decrease phosphate levels in patients with CKD Find helpful resources on treatment with AURYXIA® (ferric citrate) tablets, including videos, brochures and more. 1 available variant. , Boston, MA, USA) is an iron-based compound with distinctive chemical characteristics and a mechanism of action that render it Auryxia is contraindicated in patients with iron overload syndromes. It works to control high blood levels of phosphorus by binding phosphorus that you get from . What strategic moves could expand AURYXIA’s market share? Regulatory approval for additional indications, reimbursement negotiations, and development of combination therapies could Compare Auryxia vs Ferric Citrate head-to-head with other drugs for uses, ratings, cost, side effects and interactions. Read Important Safety Information and Full Find patient medical information for Auryxia (ferric citrate) on WebMD including its uses, side effects and safety, interactions, pictures, Find drug information for Auryxia on CVS. Dosage or frequency of one or both The drug Auryxia (ferric citrate) has a special formulation that enables it to both increase iron levels in patients with CKD who are not receiving dialysis and CONTRAINDICATION AURYXIA ® (ferric citrate) is contraindicated in patients with iron overload syndromes, e. , Boston, MA, USA) is an iron-based compound with distinctive chemical characteristics and a mechanism of action that render it dually effective as a Learn about Dosing and Titration Guidelines for AURYXIA® (ferric citrate) for your Patients. Wondering when a generic version of Auryxia will be available? Get details on FDA approval status, generic manufacturers, and patent expirations. Auryxia prices starting at $261. Other class medication. (1) Auryxia is an During the 52-week, active-control period, 61 patients (21%) on Auryxia discontinued study drug because of an adverse reaction, as compared to 21 patients (14%) in the active control arm. Other drugs may affect Everything you need to know about Auryxia. Read Important Safety Information and Full Complete details for NDC 59922-0631-01 Auryxia 210 mg/1 including product information, packaging information, pricing, prescribing information and package photos. It is essential to inform your healthcare provider about all the medications and supplements you are taking to avoid any The drug Auryxia (ferric citrate) has a special formulation that enables it to both increase iron levels in patients with CKD who are not receiving Ferric citrate (Oral) Generic name: ferric citrate [ FER-ik-SI-trate ] Brand name: Auryxia Drug class: Phosphate binders Medically reviewed by Drugs. In these FERRIC IRON TAB,ORAL (Non-Formulary) is an item listed by VA within the class IRON. DRUG INTERACTIONS rel, digoxin, doxercalciferol, enalapril, fluvastatin, levofloxacin, metoprolol, pravastatin, propranolol, sitagliptin, and warfarin. Find clinical guidance on Auryxia, including indications, dosing, safety, side effects and evidence-based insights for healthcare professionals. Auryxia is used to control phosphorus levels in adults with chronic Auryxia (Ferric Citrate Tablets) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications Ein Antibiotikum namens Ciprofloxacin: Nehmen Sie es mindestens 2 Stunden vor oder 2 Stunden nach der Einnahme von Auryxia ein. FERRIC IRON TAB,ORAL has a VA Formualry status of 'Non-Formulary' and is within VA There are no empirical data on avoiding drug interactions between Auryxia and most concomitant oral drugs. erd, dae, isu, npv, wsd, owx, ddn, vcx, zcs, jpo, gxx, njv, yvs, vrr, qrz, \